BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Staging
4 results:

  • 1. Contrast-Enhanced Ultrasonography for Transabdominal and Transrectal Ultrasound in staging cervical cancer: A Reliability Study.
    Zhang J; Xiang JD; Jia C; Du LF; Li F
    Ultrasound Med Biol; 2023 Oct; 49(10):2283-2290. PubMed ID: 37495499
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Hypermethylation of RAD51L3 and XRCC2 genes to predict late toxicity in chemoradiotherapy-treated cervical cancer patients.
    Paulíková S; Chmelařová M; Petera J; Palička V; Paulík A
    Folia Biol (Praha); 2013; 59(6):240-5. PubMed ID: 24485306
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A case of glassy cell carcinoma of the uterine cervix effectively responding to chemotherapy with paclitaxel and carboplatin.
    Hirashima Y; Kobayashi H; Nishiguchi T; Miura K; Kanayama N
    Anticancer Drugs; 2001 Aug; 12(7):627-30. PubMed ID: 11487720
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Continuous infusion of carboplatin during conventional radiotherapy treatment in advanced squamous carcinoma of the cervix uteri IIB-IIIB (UICC). A phase I/II and pharmacokinetic study.
    Micheletti E; La Face B; Bianchi E; Cagna E; Apostoli P; Ruggeri G; Verardi R; Sartori E
    Am J Clin Oncol; 1997 Dec; 20(6):613-20. PubMed ID: 9391552
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.